Clinical Trials Directory

Trials / Completed

CompletedNCT01364779

Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of the study is to determine the prevalence of aspirin resistance in chronic kidney disease patients. The secondary objectives are to determine possible risk factors contributing to aspirin resistance in this population.

Detailed description

A cross-sectional of "aspirin resistance in hemodialysis patients" previously done in our institution showed that 23/66 (34.7%) hemodialysis patients were aspirin resistant. In a recent systematic review, renal impairment was associated with aspirin resistance . This association was seen in only two out of the twenty studies used in this meta-analysis . Both these studies are from the same center with a predominant Asian population. In this study we will try to evaluate the prevalence of aspirin resistance in CKD patient without being limited to a specific ethnicity.

Conditions

Timeline

Start date
2010-04-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2011-06-02
Last updated
2013-05-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01364779. Inclusion in this directory is not an endorsement.

Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients (NCT01364779) · Clinical Trials Directory